How can CYP3A4 be targeted to reduce drug toxicity?
Strategies to reduce drug toxicity involving CYP3A4 include the use of enzyme inhibitors or inducers to modulate drug levels. Additionally, drug formulations can be designed to avoid significant CYP3A4 metabolism. Personalized medicine approaches, considering individual genetic polymorphisms, also play a vital role in minimizing toxicity.
